Publications

Bardhi A, Wu Y, Chen W, Li W, Zhu Z, Zheng JHua, Wong H, Jeng E, Jones J, Ochsenbauer C et al..  2017.  Potent NK Cell-Mediated Elimination of HIV-1-Infected Cells Mobilized by a gp120-Bispecific and Hexavalent Broadly Neutralizing Fusion Protein.. J Virol. 91(20)

Lin X..  2017.  Protein Phosphatase-1 -targeted Small Molecules, Iron Chelators and Curcumin Analogs as HIV-1 Antivirals.. Curr Pharm Des. 23(28)

Thomas A.S.  2017.  T-cell responses targeting HIV Nef uniquely correlate with infected cell frequencies after long-term antiretroviral therapy.. PLoS Pathog. 13(9)

Flerin NC, Chen H, Glover TD.  2017.  TCR Clonotype-specific Differences in Inhibitory Activity of HIV-1 Cytotoxic T Cell Clones is Not Mediated by TCR Alone. American Society for Microbiology Journals.

Pinzone MRita, Graf E, Lynch L, McLaughlin B, Hecht FM, Connors M, Migueles SA, Hwang W-T, Nunnari G, O'Doherty U.  2016.  Monitoring Integration over Time Supports a Role for Cytotoxic T Lymphocytes and Ongoing Replication as Determinants of Reservoir Size.. J Virol. 90(23):10436-10445.

Li S..  2016.  Simian Immunodeficiency Virus-Producing Cells in Follicles Are Partially Suppressed by CD8+ Cells In Vivo.. J Virol. 90(24)

Patel S..  2016.  T-cell therapies for HIV: Preclinical successes and current clinical strategies.. Cytotherapy. 18(8)